Anastrozole Tablets Prevents The Release Of Estrogen From Body And Are Available In A Convenient Tablet Form
![]() |
| Anastrozole Tablets |
Anastrozole Tablets are
anti-estrogen that prevents the release of estrogen from the body. It is used
in the treatment of breast cancer. It is approved by the U.S. Food and Drug
Administration (FDA) for use in women over the age of 40.
Although Anastrozole
is not contraindicated during pregnancy, women of reproductive age should use
effective contraception throughout their therapy and for up to three weeks
after the last dose. These Tablets may cause side effects, which are common.
However, the more serious side effects are rare and require urgent medical
attention. These include swelling of the face, lips, or tongue, rash, blisters,
or liver changes. It is advisable to avoid contact with children or pets, and
always keep the medication in its original packaging.
Anastrozole
Tablets are available in a convenient
tablet form. They should be taken once a day and should not be crushed. They
are recommended to be taken with a glass of water. These Tablets are prepared
according to a drug research guideline. In addition to the raw materials used,
the formulation also contains magnesium stearate, povidone, and sodium
carboxymethyl starch. The Anastrozole tablet preparation method is suitable for
industrial production. The Tablets have good mobility and compression
properties.
Although Anastrozole
has a low risk for severe toxicity. For instance, Anastrozole may cause liver
inflammation. This can lead to worsening liver problems. Therefore, patients
with liver problems are not advisable take these Tablets.
Although Anastrozole
crosses the placenta during organogenesis, it has been shown to have adverse
effects in pregnant rabbits and rats. In rats, Anastrozole treatment led to
pregnancy loss and decreased a number of live fetuses. The effects were
dose-related. In rats, the dosage was equivalent to about 1/3 of the maximum
recommended human dosage.
Read the Complete Press Release- https://www.coherentmarketinsights.com/press-release/anastrozole-tablets-market-3086

Comments
Post a Comment